| |||||||||||
| |||||||||||
| |||||||||||
| |||||||||||
| |||||||||||
|
TropMed Sponsored Research Funding Opportunities: this blog is designed to alert TropMed researchers to funding opportunities to support their research. The Research Administration Unit of the Office of Research Services (ORS) is here to help staff members with all application, grant management, and post-grant processes. Please contact Mr. Paul Adams or Mr. Oiko Tacusalme on ext. 1332 for more information, or to express interest in any of these grant opportunities.
Wednesday, October 10, 2012
BMGF Grand Challenges Explorations Round 10 Now Open
Friday, October 5, 2012
NIH Grant: Immunity in the Elderly (R01) (RFA-AI-12-038)
Immunity in the Elderly
The National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Aging (NIA) invite applications to define the mechanisms for induction, development, and maintenance of protective immunity in the elderly in response to infections with or vaccinations against NIAID Emerging and Re-emerging Infectious Diseases
The goal of this FOA is to develop a better understanding of the immune mechanisms involved during the aging process that contribute to impaired immune responses resulting in severe infections and dampened responses to vaccines in this population. This FOA requires human studies, to gain insights into immune changes in elderly individuals. Thus, at least one aim of the project must focus fully on human studies; appropriately justified animal work may be included in additional aims to conduct mechanistic studies that are not possible in humans.
Funding Opportunity Announcement (FOA) Number
|
RFA-AI-12-038
|
Open Date (Earliest Submission Date)
|
January 18, 2013
|
Letter of Intent Due Date
|
January 18, 2013
|
Application Due Date(s)
|
February 20, 2013
|
Funds Available and Anticipated Number of Awards
|
The following NIH components intend to commit the following amounts in FY2014:
NIAID, $4 million, 8-10 awards NIA, $2 million, 4-5 awards |
Award Budget
|
Direct costs for each application are expected to be $300,000 or less per year, plus appropriate F&A costs. Budgets should be commensurate with the proposed studies and adequately justified.
|
Award Project Period
|
Scope of the proposed project should determine the project period. The maximum period is 5 years.
|
The original announcement and further details are available at:
Wednesday, October 3, 2012
REMINDER: TDR Clinical Research & Development Fellowships
REMINDER!
Applications must be received by 7th October 2012
Researchers from low and middle income countries (LMICs) are invited to apply for the fourth round of the WHO/TDR Career Development Fellowship (CDF) on clinical research & development (clinical R&D). Successful candidates will be placed with leading product development institutions, including pharmaceutical companies that are participating in the fellowship programme (“host institutions”). The goal is to develop human resources to promote high quality clinical R&D in LMICs. It is expected that qualified professionals will enhance LMICs’ product development capacity on diagnostics, drugs and vaccines for infectious diseases that disproportionately affect poor and marginalized populations.
The host institutions will train individuals in situ in order to develop specialized skills not readily taught in academic centres, including R&D project management, regulatory requirements and good health research practices. On returning to their home institutions, the fellows are expected to become an important resource for institutional capacity development to undertake and manage clinical research in accordance with international regulatory requirements and standards.
Subscribe to:
Posts (Atom)